Abstract
Chitosan has been investigated as a non‐viral vector because it has several advantages such as biocompatibility, biodegradability, and low toxicity. However, low specificity and low transfection efficiency of chitosan as a DNA carrier need to be overcome prior to clinical trial. In this review paper, chemical modification of chitosan was tried in order to enhance cell specificity and transfection efficiency. Also, chemical modification of chitosan was performed to increase stability of chitosan/DNA complexes.
Acknowledgment
This work was supported by a grant of the Korean Ministry of Public Health and Welfare (02‐PJ3‐PG3‐31402‐0017).